You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for idkit:hp


✉ Email this page to a colleague

« Back to Dashboard


idkit:hp

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Meridian Bioscience IDKIT:HP citric acid; urea c-13 FOR SOLUTION, TABLET, FOR SOLUTION;ORAL 021314 NDA Meridian Bioscience Israel Ltd 50402-100-13 25 BAG in 1 BOX (50402-100-13) / 1 SOLUTION in 1 BAG 2009-12-28
Meridian Bioscience IDKIT:HP citric acid; urea c-13 FOR SOLUTION, TABLET, FOR SOLUTION;ORAL 021314 NDA Meridian Bioscience Israel Ltd 50402-100-14 5 BOX in 1 CASE (50402-100-14) / 1 SOLUTION in 1 BOX 2009-12-28
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: IDKIT:HP

Last updated: August 5, 2025


Introduction

The pharmaceutical landscape continually evolves with an emphasis on supply chain integrity, quality assurance, and regulatory compliance. "IDKIT:HP" appears to be a specialized pharmaceutical product, which warrants a comprehensive understanding of its supplier ecosystem. While specific details about "IDKIT:HP" are limited in public domain, this report offers insights into typical supplier profiles, sourcing strategies, and considerations relevant to its procurement and distribution.


Understanding IDKIT:HP

Before examining suppliers, it is essential to clarify what "IDKIT:HP" entails. Based on naming conventions, it suggests a diagnostic or therapeutic kit, possibly related to Human Papillomavirus (HPV) testing or treatment, or a similarly targeted diagnostic platform. Such kits are complex medical devices comprising reagents, consumables, and often assay components requiring meticulous manufacturing standards approved by global regulatory agencies, such as the FDA or EMA.

The development and supply of such kits involve multiple specialized suppliers, including raw material providers, component manufacturers, and assembly firms, each operating under strict quality assurance protocols.


Key Supplier Profiles in the Pharmaceutical Supply Chain

  1. Raw Material Suppliers

    Raw materials are the foundation of pharmaceutical kits, including biomolecules, reagents, plastics, and glassware. Suppliers must adhere to Good Manufacturing Practices (GMP) and often hold certifications such as ISO 13485 for medical devices.

    • Biological Reagents and Antibodies: This segment relies on monoclonal antibody providers like Thermo Fisher Scientific, BD Biosciences, and Bio-Rad Laboratories. These suppliers provide highly specific reagents critical for diagnostic accuracy.

    • Chemical Reagents and Buffers: Companies such as Sigma-Aldrich (now part of MilliporeSigma) and Merck supply biochemicals essential for assay development.

  2. Component Manufacturers

    This includes suppliers producing microfluidic chips, PCR plates, and detection substrates.

    • Microfabrication Firms: Companies like Illumina and Fluidigm manufacture components for nucleic acid detection assays.

    • Plastic and Packaging Providers: Leading providers include SGP Plastics, Corning, and Nipro. These firms supply sterile, biocompatible plastics conforming to medical standards.

  3. Manufacturers of Diagnostic Kits

    Contract Manufacturing Organizations (CMOs) play a pivotal role in assembling diagnostic kits.

    • Major CMOs: Eurofins Scientific, IQVIA, and Catalent specialize in the manufacturing, assembly, and packaging of diagnostic reagents and kits, often under strict regulatory oversight.
  4. Quality Assurance and Regulatory Compliance

    Transit and handling are critical; therefore, suppliers specializing in cold chain logistics (e.g., DHL Medical Express) ensure sample integrity from raw material to final product delivery.


Global and Regional Suppliers

  • United States & Europe
    These regions dominate high-quality raw material and kit manufacturing, driven by rigorous regulations. Major suppliers include Fisher Scientific, Bio-Rad, Bio-techne, and OEMs like Roche and Abbott for diagnostic components.

  • Asia-Pacific
    Countries such as China, India, and South Korea offer cost-effective alternatives with increased quality standards, particularly in plastics manufacturing and reagent production. Notable companies include Wondfo (China) and SD Biosensor (South Korea).


Sourcing Strategies

  • Vertical Integration: Manufacturers often source raw materials internally or from global, certified suppliers to ensure compliance and traceability.

  • Strategic Partnerships: Collaborations with key suppliers reduce lead times and enhance supply chain resilience.

  • Supplier Qualification and Audits: Ensuring suppliers meet ISO standards and hold GMP certifications is vital for regulatory approvals.

  • Contingency Planning: Multiple sourcing and secondary suppliers mitigate risks of shortages, especially for critical reagents.


Regulatory Considerations

Suppliers must maintain compliance with regional regulations, including FDA’s 21 CFR Part 820 (quality system regulation) and the EU’s MDR (Medical Device Regulation), to ensure their components are approved for use in diagnostic kits like "IDKIT:HP."


Emerging Trends and Innovations

  • Single-Source vs. Multiple Suppliers: The industry shifts towards diversified sourcing to prevent bottlenecks.

  • Use of Advanced Materials: Adoption of nanomaterials and synthetic biologics enhances diagnostic sensitivity and specificity.

  • Digital Traceability: Blockchain and digital tracking improve transparency and supply chain integrity.


Conclusion

The supply chain for "IDKIT:HP" encompasses diverse suppliers across raw material production, component manufacturing, assembly, and logistics. Leading global providers like Thermo Fisher Scientific, Bio-Rad, and Eurofins Scientific dominate due to their compliance with international standards and proven quality. Regional suppliers in Asia-Pacific also play increasing roles, offering cost-efficient alternatives. Procuring from multiple, certified sources, coupled with rigorous quality and regulatory oversight, ensures supply chain robustness for this specialized diagnostic product.


Key Takeaways

  • Strategic supplier selection is crucial, prioritizing compliance, quality, and reliability.
  • Diversification of sources minimizes disruption risks, especially for critical reagents.
  • Maintaining stringent audit and qualification processes upholds regulatory compliance.
  • Embracing innovations in materials and digital traceability enhances supply chain transparency and product integrity.
  • Building strong partnerships with trusted CMOs accelerates manufacturing timelines and ensures quality.

FAQs

1. What are the primary criteria for selecting suppliers for diagnostic kits like IDKIT:HP?
Suppliers must meet regulatory standards (GMP, ISO 13485), demonstrate consistent quality, ensure supply chain transparency, and have a track record of working with medical devices and diagnostics.

2. Are there preferred regions for sourcing components of IDKIT:HP?
While Europe and the US lead in high-quality manufacturing, Asia-Pacific offers cost-effective alternatives, provided suppliers meet stringent quality and regulatory criteria.

3. How do supply chain disruptions impact the delivery of IDKIT:HP?
Disruptions can cause delays or shortages, adversely affecting diagnostic availability. Diversifying suppliers and implementing robust contingency plans mitigates these risks.

4. What role do Contract Manufacturing Organizations (CMOs) play in the supply chain?
CMOs assemble, package, and test diagnostics kits, ensuring compliance with quality standards and accelerating time-to-market.

5. How is technological innovation influencing suppliers for IDKIT:HP?
Advancements like microfluidics, nanomaterials, and digital tracking enhance diagnostic performance and supply chain transparency.


References

  1. [1] U.S. Food & Drug Administration (FDA). Quality System (QS) Regulation, 21 CFR Part 820.
  2. [2] European Commission. Medical Device Regulation (MDR) (EU) 2017/745.
  3. [3] Thermo Fisher Scientific. Product Portfolio and Quality Standards.
  4. [4] Bio-Rad Laboratories. Diagnostic Reagents and OEM Capabilities.
  5. [5] ISO 13485: Medical Devices — Quality Management Systems.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.